Literature DB >> 84055

Modifications of the cerebrospinal fluid IgG concentrations in patients with multiple sclerosis treated with intrathecal steroids.

A R Massaro.   

Abstract

Forty-one patients with multiple sclerosis (MS), in the acute exacerbation phase of the disease, were treated with three or four intrathecal injections of triamcinolone retard, 40 mg. Cerebrospinal fluid (CSF) specimens were collected at the first and at the last lumbar puncture, and analyzed for IgG and Albumin. There was a decrease of CSF IgG concentration in the specimens of 85% of the cases which were collected at the last lumbar puncture, compared to the initial concentration. Similarly, the CSF IgG/albumin ratio in the last specimens collected were reduced in 78% of the cases. Both these results are statistically significant.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 84055     DOI: 10.1007/BF00312975

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  17 in total

1.  Sclerosing spinal pachymeningitis. A complication of intrathecal administration of Depo-Medrol for multiple sclerosis.

Authors:  J L Bernat; C H Sadowsky; F M Vincent; R E Nordgren; G Margolis
Journal:  J Neurol Neurosurg Psychiatry       Date:  1976-11       Impact factor: 10.154

2.  Predictable remissions in multiple sclerosis.

Authors:  G J BOINES
Journal:  Del Med J       Date:  1963-08

3.  Subdural administration of hydrocortisone in multiple sclerosis: effect of ACTH.

Authors:  G F KAMEN; G L ERDMAN
Journal:  J Am Geriatr Soc       Date:  1953-11       Impact factor: 5.562

4.  Myelin basic protein in cerebrospinal fluid as an indicator of active demyelination.

Authors:  S R Cohen; R M Herndon; G M McKhann
Journal:  Trans Am Neurol Assoc       Date:  1976

5.  [Gamma globulins in the cerebrospinal fluid determined by radial immunodiffusion. Their importance in multiple sclerosis].

Authors:  P Pola; A Candido; A Massaro; L Savi; D Melina; G Di Trapani
Journal:  Acta Neurol (Napoli)       Date:  1974 Nov-Dec

6.  Complications from intrathecal steroid therapy in patients wsith multiple sclerosis.

Authors:  D A Nelson; T S Vates; R B Thomas
Journal:  Acta Neurol Scand       Date:  1973       Impact factor: 3.209

7.  Immunochemical quantitation of antigens by single radial immunodiffusion.

Authors:  G Mancini; A O Carbonara; J F Heremans
Journal:  Immunochemistry       Date:  1965-09

8.  Experimental intrathecal administration of methylprednisolone acetate in multiple sclerosis.

Authors:  N P Goldstein; W F McGuckin; B F McKenzie; V R Mattox
Journal:  Trans Am Neurol Assoc       Date:  1970

9.  Cerebrospinal fluid proteins in multiple sclerosis.

Authors:  G Lamoureux; R Jolicoeur; N Giard; M St-Hilaire; F Duplantis
Journal:  Neurology       Date:  1975-06       Impact factor: 9.910

10.  The course of multiple sclerosis cases with extremely high gamma-globulin values in the cerebrospinal fluid.

Authors:  R Schmidt; H P Rieder; R Wüthrich
Journal:  Eur Neurol       Date:  1977       Impact factor: 1.710

View more
  3 in total

1.  Intrathecal methylprednisolone acetate in multiple sclerosis treatment: effect on the blood-CSF barrier and on the intrathecal IgG production.

Authors:  B Rocchelli; M Poloni; P Mazzarello; G Piccolo; M Delodovici; P Pinelli
Journal:  Ital J Neurol Sci       Date:  1982-07

2.  Intrathecal versus systemic corticosteroids in the treatment of multiple sclerosis: results of a pilot study.

Authors:  R Heun; U Sliwka; H Rüttinger; K Schimrigk
Journal:  J Neurol       Date:  1992-01       Impact factor: 4.849

Review 3.  Intrathecal IgG synthesis: a resistant and valuable target for future multiple sclerosis treatments.

Authors:  Mickael Bonnan
Journal:  Mult Scler Int       Date:  2015-01-08
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.